Independent. No paid placement. Reviewed weekly Editorial policy Newsletter

HomeThe LibraryDo they actually work?

Do copper peptides actually work?

Yes — for firmness and fine lines, with real human evidence behind it. No — for most of the other things they are sold for.

In brief

Should you care? Copper peptides are one of a small handful of skincare ingredients where the answer to “does it work” is genuinely yes. One comparative trial found it increased collagen deposition in 70% of participants after a month — more than vitamin C or retinoic acid in the same study.1 The catch is that the hair and injectable claims stacked on top of that finding are not supported, and many products under-dose the thing you are paying for.

The short version

  • Works for: firmness, fine lines, texture, repair.
  • Doesn't work for: hair growth, acne, or as an injectable.
  • The real risk: not the ingredient — the formulation.

What "works" means here

Almost every ingredient in skincare can point at some study. The question worth asking is what kind — and most marketing hides where on the ladder a claim actually sits.

Evidence hierarchy, and where copper peptides sit
Kind of evidenceWhat it tells youCopper peptides
Cells in a dishSomething happens in a laboratory; often does not survive contact with skinYes
Animal studiesSuggestive; frequently does not translate to humansYes
Human trialMeasured in people, with a measured endpointYes
Repeated human trialsThe finding holds up independentlyLimited

They clear the human-trial bar, which most peptides in skincare do not. They do not have a deep body of repeated independent trials — hence grade A rather than anything higher.

Where the claims stop being supported

Sold on the back of one finding

  • Hair regrowth. The trail leads to animal studies and patents, not human trials.3
  • Acne. No meaningful evidence either way. Anyone telling you it clears acne is guessing.
  • Injectable GHK-Cu. Different route, no human efficacy data, not an approved medicine.
  • "Reverses ageing." It increases a measurable protein. That is not the same sentence.

What actually decides whether it works for you

Not whether the ingredient is real — it is. Whether the product is built properly. Three formulation failures are common enough that they are probably the main reason people report nothing:

  1. Under-dosing. An ingredient listed near the bottom of the label is present in token amounts.
  2. Wrong pH. Outside roughly 5.0–6.5 the molecule degrades.5 The detail is here.
  3. Chelators in the formula. EDTA and similar agents pull the copper out and inactivate it.6

This is why our assessment asks brands for the percentage and the pH before anything is listed. It is not pedantry — it is the difference between a product that can do what the research describes and one that cannot.

So should you buy one?

If your concern is firmness and fine lines and you will give it twelve weeks: yes, it is among the better-evidenced choices available. If you want it for hair: no. If you can only afford one product and you are not using sunscreen daily, buy sunscreen.

References

  1. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data" — comparative collagen-deposition trial and 12-week cream trial. pmc.ncbi.nlm.nih.gov/articles/PMC6073405
  2. Badenhorst T, Svirskis D, Merrilees M, Bölke L, Wu Z (2016), "Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters," Journal of Aging Science 4:166. DOI: 10.4172/2329-8847.1000166
  3. US Patents 5,120,831, 5,177,061, 5,538,945 and 5,550,183 (Pickart) — the origin of the hair-growth claim, not evidence it holds in humans. See do peptides work for hair growth?
  4. US FDA cosmetic labelling guidance.
  5. Badenhorst T, Svirskis D, Wu Z (2016), "Physicochemical characterization of native glycyl-L-histidyl-L-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery," Pharmaceutical Development and Technology 21(2):152–160. DOI: 10.3109/10837450.2014.979944
  6. The higher copper-binding affinity of EDTA (log K ≈ 18.8) versus GHK's (log K ≈ 16.5–17, per Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J (1982), "Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution," Biochemistry 21(19):4540–4544) means EDTA would be expected to strip copper from the complex. This is a chemical inference from established binding constants, not a study that directly tested EDTA against a finished GHK-Cu cosmetic formulation.